Heparin-associated thrombocytopenia type II in a patient with end-stage renal disease: successful anticoagulation with the low-molecular-weight heparinoid Org 10172 during haemodialysis.
Greinacher
A
A
Institute for Clinical Immunology and Transfusion Medizin, Justus Liebig University, Giessen, Germany.
Philippen
K H
KH
Kemkes-Matthes
B
B
Möckl
M
M
Mueller-Eckhardt
C
C
Schaefer
K
K
D000368:Aged; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D005260:Female; D006025:Glycosaminoglycans / Q000737:chemistry / Q000627:therapeutic use; D006493:Heparin / Q000009:adverse effects*; D006496:Heparinoids / Q000627:therapeutic use; D006497:Heparan Sulfate; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D008970:Molecular Weight; D006435:Renal Dialysis / Q000379:methods; D013921:Thrombocytopenia / Q000139:chemically induced*
D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D006025:Glycosaminoglycans; D006493:Heparin; D006496:Heparinoids; D006497:Heparan Sulfate; C035838:danaparoid